Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2

  • Wu, Liu-Qing (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Li, Yu (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Li, Yuan-Yan (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Xu, Shi-hao (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Yang, Zong-Yong (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Lin, Zheng (Department of Anesthesiology, Wenzhou Central Hospital) ;
  • Li, Jun (Department of Anesthesiology, Second Affiliated Hospital of Wenzhou Medical University)
  • Received : 2015.10.15
  • Accepted : 2016.03.24
  • Published : 2016.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

We measured anti-nociceptive activity of prim-o-glucosylcimifugin (POG), a molecule from Saposhnikovia divaricate (Turcz) Schischk. Anti-nociceptive or anti-inflammatory effects of POG on a formalin-induced tonic nociceptive response and a complete Freund's adjuvant (CFA) inoculation-induced rat arthritis pain model were studied. Single subcutaneous injections of POG produced potent anti-nociception in both models that was comparable to indomethacin analgesia. Anti-nociceptive activity of POG was dose-dependent, maximally reducing pain 56.6% with an $ED_{50}$ of 1.6 mg. Rats given POG over time did not develop tolerance. POG also time-dependently reduced serum TNF${\alpha}$, IL-$1{\beta}$ and IL-6 in arthritic rats and both POG and indomethacin reduced spinal prostaglandin E2 ($PGE_2$). Like indomethacin which inhibits cyclooxygenase-2 (COX-2) activity, POG dose-dependently decreased spinal COX-2 content in arthritic rats. Additionally, POG, and its metabolite cimifugin, downregulated COX-2 expression in vitro. Thus, POG produced potent anti-nociception by downregulating spinal COX-2 expression.

Keywords

References

  1. Agarwal, S. and Das, S. K. (2013) Rheumatoid arthritis with increased bone mineral density. Int. J. Rheum. Dis. 16, 762-763. https://doi.org/10.1111/1756-185X.12192
  2. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C. and Gregory, S. A. (1996) Selective inhibition of cyclooxygenase (Cox)-2 reverses inflammation and expression of Cox-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97, 2672-2679. https://doi.org/10.1172/JCI118717
  3. Beaugerie, L., Berenbaum, F., Berrebi, D., Gendre, J. P., Prier, A., Kaplan, G. and Chatelet, F. P. (2001) Chronic use of non-steroidal anti-inflammatory drugs does not alter colonic mucosa of patients without diarrhoea. Aliment. Pharmacol. Ther. 15, 1301-1306. https://doi.org/10.1046/j.1365-2036.2001.01059.x
  4. Beiche, F., Brune, K., Geisslinger, G. and Goppelt-Struebe, M. (1998) Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm. Res. 47, 482-487. https://doi.org/10.1007/s000110050362
  5. Costa, M. D. C., De Sutter, P., Gybels, J. and Van Hees, J. (1981) Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain 10, 173-185. https://doi.org/10.1016/0304-3959(81)90193-7
  6. Crofford, L. J. (1997) Cox-1 and Cox-2 tissue expression: implications and predictions. J. Rheumatol. Suppl. 49, 15-19.
  7. Dai, J., Chen, X., Cheng, W., Liu, X., Fan, X., Shen, Z. and Bi, K. (2008) A sensitive liquid chromatography-mass spectrometry method for simultaneous determination of two active chromones from saposhnikovia root in rat plasma and urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 868, 13-19. https://doi.org/10.1016/j.jchromb.2008.03.031
  8. Deng, C., Yang, X. and Zhang, X. (2005) Rapid determination of panaxynol in a traditional chinese medicine of saposhnikovia divaricata by pressurized hot water extraction followed by liquid-phase microextraction and gas chromatography-mass spectrometry. Talanta 68, 6-11. https://doi.org/10.1016/j.talanta.2005.04.040
  9. Dubuisson, D. and Dennis, S. G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4, 161-174. https://doi.org/10.1016/0304-3959(77)90130-0
  10. Ebersberger, A., Grubb, B. D., Willingale, H. L., Gardiner, N. J., Nebe, J. and Schaible, H. G. (1999) The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an upregulation of cyclo-oxygenase-2 in the spinal cord. Neuroscience 93, 775-781. https://doi.org/10.1016/S0306-4522(99)00164-5
  11. Esfahani, H. M., Esfahani, Z. N., Dehaghi, N. K., Hosseini-Sharifabad, A., Tabrizian, K., Parsa, M. and Ostad, S. N. (2012) Anti-inflammatory and anti-nociceptive effects of the ethanolic extracts of alkanna frigida and alkanna orientalis. J. Nat. Med. 66, 447-452. https://doi.org/10.1007/s11418-011-0603-1
  12. Gong, N., Fan, H., Ma, A.-N., Xiao, Q. and Wang, Y.-X. (2014) Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal Glp-1 receptors. Neuropharmacology 84, 31-45. https://doi.org/10.1016/j.neuropharm.2014.04.007
  13. Granados-Soto, V., Rufino, M. O., Gomes Lopes, L. D. and Ferreira, S. H. (1997) Evidence for the involvement of the nitric oxide-cgmp pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340, 177-180. https://doi.org/10.1016/S0014-2999(97)01399-X
  14. Hammoudeh, M., Al Awadhi, A., Hasan, E. H., Akhlaghi, M., Ahmadzadeh, A. and Sadeghi Abdollahi, B. (2015) Safety, tolerability, and efficacy of tocilizumab in rheumatoid arthritis: an open-label phase 4 study in patients from the middle east. Int. J. Rheumatol. 2015, 975028.
  15. Han, Y. K., Lee, S. H., Jeong, H. J., Kim, M. S., Yoon, M. H. and Kim, W. M. (2012) Analgesic effects of intrathecal curcumin in the rat formalin test. Korean J. Pain 25, 1-6. https://doi.org/10.3344/kjp.2012.25.1.1
  16. He, Q. J., Gao, Y. H. and Wei, Z. X. (2009) Determination of primo-glucosylcimifugin in biyan tablets by Hplc. Zhongyao Xinyao Yu Linchuang Yaoli 3, 25-28.
  17. Hua, J., Suguro, S., Hirano, S., Sakamoto, K. and Nagaoka, I. (2005) Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm. Res. 54, 127-132. https://doi.org/10.1007/s00011-004-1333-6
  18. Hunskaar, S. and Hole, K. (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30, 103-114. https://doi.org/10.1016/0304-3959(87)90088-1
  19. Jiang, Y. Y., Liu, B. and Shi, R. B. (2006) Hplc determination of the contents of four components in the chromone fraction of saposhnikovia divaricata (turcz.) Schischk. J. Beijing Univ. Trad. Chin. Med. 2, 15-17.
  20. Kageyama, Y., Torikai, E., Tsujimura, K. and Kobayashi, M. (2012) Involvement of Il-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of Il-33. Mod. Rheumatol. 22, 89-93. https://doi.org/10.3109/s10165-011-0480-1
  21. Keiserman, M., Codreanu, C., Handa, R., Xibille-Friedmann, D., Mysler, E., Briceno, F. and Akar, S. (2014) The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences. Expert Rev. Clin. Immunol. 10, 1049-1057. https://doi.org/10.1586/1744666X.2014.926219
  22. Kim, G. W., Lee, N. R., Pi, R. H., Lim, Y. S., Lee, Y. M., Lee, J. M., Jeong, H. S. and Chung, S. H. (2015) Il-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future. Arch. Pharm. Res. 38, 575-584. https://doi.org/10.1007/s12272-015-0569-8
  23. Klimiuk, P. A., Sierakowski, S., Domyslawska, I. and Chwiecko, J. (2006) Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24, 529-533.
  24. Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E. R., Van, G., Nguyen, L. T., Ohashi, P. S., Lacey, D. L., Fish, E., Boyle, W. J. and Penninger, J. M. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309. https://doi.org/10.1038/46303
  25. Lee, K. M., Kang, B. S., Lee, H. L., Son, S. J., Hwang, S. H., Kim, D. S., Park, J. S. and Cho, H. J. (2004) Spinal $NF-{\kappa}B$ activation induces Cox-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. Neurosci. 19, 3375-3381. https://doi.org/10.1111/j.0953-816X.2004.03441.x
  26. Li, T.-X., Hu, L., Zhang, M.-M., Sun, J., Qiu, Y., Rui, J.-Q. and Yang, X.-H. (2014) A Sensitive Uplc-Ms/Ms method for simultaneous determination of eleven bioactive components of Tong-Xie-Yao-Fang decoction in rat biological matrices. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 944, 90-100. https://doi.org/10.1016/j.jchromb.2013.11.015
  27. Li, X., Hu, Y., Wu, Y., Huang, Y., Yu, S., Ding, Q., Zhangsun, D. and Luo, S. (2016) Anti-hypersensitive effect of intramuscular administration of Ao-Conotoxin Gexiva [1,2] and Gexiva [1,4] in rats of neuropathic pain. Prog. Neuropsychopharmacol. Biol. Psychiatry 66, 112-119. https://doi.org/10.1016/j.pnpbp.2015.12.005
  28. McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A. and FitzGerald, G. A. (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (Cox)-2: the human pharmacology of a selective inhibitor of Cox-2. Proc. Natl. Acad. Sci. U.S.A. 96, 272-277. https://doi.org/10.1073/pnas.96.1.272
  29. McCoy, J. M., Wicks, J. R. and Audoly, L. P. (2002) The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110, 651-658. https://doi.org/10.1172/JCI0215528
  30. Nagakura, Y., Okada, M., Kohara, A., Kiso, T., Toya, T., Iwai, A., Wanibuchi, F. and Yamaguchi, T. (2003) Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J. Pharmacol. Exp. Ther. 306, 490-497. https://doi.org/10.1124/jpet.103.050781
  31. Ocvirk, R., Pearson Murphy, B. E., Franklin, K. B. and Abbott, F. V. (2008) Antinociceptive profile of ring A-reduced progesterone metabolites in the formalin test. Pain 138, 402-409. https://doi.org/10.1016/j.pain.2008.01.019
  32. Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V. and Woolf, C. J. (2001) Interleukin-1bmediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471-475. https://doi.org/10.1038/35068566
  33. Schafers, M., Svensson, C. I., Sommer, C. and Sorkin, L. S. (2003) Tumor necrosis factor-a induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 2517-2521. https://doi.org/10.1523/JNEUROSCI.23-07-02517.2003
  34. van Eden, W., Wagenaar-Hilbers, J. and Wauben, M. H. (2001) Adjuvant arthritis in the rat. Curr. Protoc. Immunol. Chapter 15, Unit 15.4.
  35. Vissers, K., Hoffmann, V., Geenen, F., Biermans, R. and Meert, T. (2003) Is the second phase of the formalin test useful to predict activity in chronic constriction injury models? A pharmacological comparison in different species. Pain Pract. 3, 298-309. https://doi.org/10.1111/j.1530-7085.2003.03033.x
  36. Wang, C.-C., Chen, L.-G. and Yang, L.-L. (1999) Inducible nitric oxide synthase inhibitor of the Chinese Herb I. Saposhnikovia Divaricata (Turcz.) schischk. Cancer Lett. 145, 151-157. https://doi.org/10.1016/S0304-3835(99)00248-7
  37. Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A. and Chartash, E. K. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the armada trial. Arthritis Rheum. 48, 35-45. https://doi.org/10.1002/art.10697
  38. Xue, B. Y., Li, W., Li, L. and Xiao, Y. Q. (2000) A pharmacodynamic research on chromone glucosides of fangfeng. Zhongguo Zhong Yao Za Zhi 25, 297-299.
  39. Yamashita, K., Fukusaki, M., Ando, Y., Fujinaga, A., Tanabe, T., Terao, Y. and Sumikawa, K. (2006) Preoperative administration of intravenous flurbiprofen axetil reduces postoperative pain for spinal fusion surgery. J. Anesth. 20, 92-95. https://doi.org/10.1007/s00540-006-0389-6
  40. Zeilhofer, H. U. (2007) Prostanoids in nociception and pain. Biochem. Pharmacol. 73, 165-174. https://doi.org/10.1016/j.bcp.2006.07.037

Cited by

  1. (USA300) vol.2018, pp.1741-4288, 2018, https://doi.org/10.1155/2018/7579808
  2. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells vol.7, pp.1, 2016, https://doi.org/10.1186/s40425-019-0676-z
  3. Panaxynol from Saposhnikovia diviaricata exhibits a hepatoprotective effect against lipopolysaccharide + D-Gal N induced acute liver injury by inhibiting Nf-κB/IκB-α and activating N vol.95, pp.8, 2020, https://doi.org/10.1080/10520295.2020.1742932
  4. Revealing the potential pharmacological mechanism of traditional Chinese medicine by integrating metabolite profiling of a Q-marker and network pharmacology, prim-O-glucosylcimifugin as an example vol.45, pp.34, 2016, https://doi.org/10.1039/d1nj02209a